Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Down 9.0% in October

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 258,800 shares, a drop of 9.0% from the October 15th total of 284,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 2,588.0 days.

Basilea Pharmaceutica Price Performance

Shares of BPMUF opened at $41.00 on Friday. The company has a quick ratio of 2.38, a current ratio of 2.77 and a debt-to-equity ratio of 7.55. The stock’s fifty day simple moving average is $46.04 and its 200 day simple moving average is $48.76. Basilea Pharmaceutica has a twelve month low of $41.00 and a twelve month high of $41.00.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive fungal infections in Japan.